Regulatory & Legal

With a star-studded new advisory board, Pilatus Biosciences accelerates its attack on cancer's metabolic defenses with its lead drug, PLT012.

Minerva Neurosciences launches a pivotal Phase 3 trial for roluperidone, a potential first-in-class drug for the untreated negative symptoms of schizophrenia.

The WPO's 50 Fastest list reveals women-owned businesses are not just growing, they're setting new standards for innovation and economic impact.

New research reveals AI is not just hype for manufacturers. Early adopters see real value in months, leaving hesitant competitors far behind.

A new partnership aims to replace perception with performance data, allowing crypto projects to vet liquidity partners with unprecedented clarity.

A global nonprofit is championing a new front in the fight against poverty, arguing that financial aid alone isn't enough without mental health support.

Cambridge Savings is acquiring NH's First Seacoast Bancorp in a deal that expands its footprint and signals major consolidation in regional community banking.

Following a landmark FDA approval and strong earnings, Axsome must convince investors its momentum can translate into long-term profitability and leadership.

As federal funding for psychedelic therapy surges, practitioners warn that a critical lack of patient preparation and integration support could undermine healing.

AcreTrader's latest deal delivered big returns for investors and let a local family buy the land. Is this a new model for harmony or just a new land rush?

With new strategic financing and powerhouse board appointments, 4D Path is accelerating its novel AI platform that predicts cancer treatment success from a single slide.

A new firm will underwrite a $400M fund, signaling a shift in patent finance toward specialized expertise and empowering small inventors.

Promising data for its lead drug budoprutug has Climb Bio on a path to potentially redefine treatment for a range of debilitating autoimmune diseases.

A novel gene therapy aims to cross the blood-brain barrier, offering new hope for Tuberous Sclerosis Complex, thanks to a powerful new partnership.

On World Hand Hygiene Day, experts warn of waning habits post-pandemic. Discover the simple, life-saving power of a 20-second scrub and its huge impact.

With profits up and a new CEO, TVA is pouring billions into new generation, betting on advanced nuclear power to meet soaring demand from data centers.

A breakthrough study validates a low-cost blood test that can detect multiple cancers and liver diseases, poised to transform preventative healthcare.

Operational failures at a key new mine pushed Peabody to a Q1 loss, overshadowing strong thermal coal profits fueled by geopolitical conflict.

Giyani Metals' high-purity manganese meets quality standards from US tech leader C4V, a crucial step in building a non-Chinese battery supply chain.

PowerBank's new 4.99 MW battery in Cramahe is online, boasting a lucrative 22-year contract and a groundbreaking 50% First Nations ownership stake.